|
Market Closed -
NSE India S.E.
05:23:30 07/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 1,395.00 INR | +0.72% |
|
-1.01% | -7.70% |
| 03/09 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 25/08 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
ETFs positioned on Cipla Limited
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +13.55% | -.--% | 27,154 M€ | |
| +15.76% | -.--% | 1,674 M€ | |
| +8.55% | -.--% | 37 M€ | |
| +11.17% | -.--% | 67 M€ | |
| +23.94% | -.--% | 9,273 M€ | |
| -8.07% | 2.13% | 118 M€ | |
| -13.30% | 1.26% | 125 M€ | |
| -10.28% | 1.12% | 48 M€ | |
| -19.05% | 0.76% | 124 M€ | |
| +22.44% | 0.75% | 122 M€ | |
| -8.11% | 0.72% | 6 M€ | |
| +52.75% | 0.72% | 18 M€ | |
| -10.50% | 0.71% | 96 M€ | |
| -10.84% | 0.69% | 5,254 M€ | |
| -10.11% | 0.68% | 2 M€ | |
| -17.55% | 0.66% | 108 M€ | |
| -11.26% | 0.66% | 565 M€ | |
| -7.66% | 0.55% | 6,661 M€ | |
| +19.17% | 0.54% | 86 M€ | |
| +20.00% | 0.53% | 3,601 M€ | |
| +20.90% | 0.52% | 491 M€ | |
| -8.18% | 0.51% | 99 M€ | |
| +31.00% | 0.49% | 68 M€ | |
| -6.49% | 0.47% | 2,189 M€ | |
| -7.10% | 0.46% | 2,692 M€ | |
| +33.14% | 0.45% | 148 M€ | |
| -6.13% | 0.45% | 49 M€ | |
| -6.37% | 0.4% | 2,054 M€ | |
| -7.20% | 0.37% | 5 M€ | |
| +25.69% | 0.28% | 60 M€ | |
| +14.43% | 0.27% | 1,125 M€ | |
| +23.33% | 0.26% | 180 M€ | |
| +26.31% | 0.25% | 164 M€ | |
| +10.84% | 0.25% | 1,545 M€ |
Employees
31,369
Sector
Pharmaceuticals
- Stock Market
- Stocks
- CIPLA Stock
- ETFs Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
